Gloria Iacoboni (G Iacoboni)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 30

Top Topics

Chronic Lymphocytic Leukemia

Mesenchymal Stem Cells

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Rejeski, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT Grading for ICAHT after CAR-T: Comparative Incidence and Association with Infections and Mortality. Blood advances (2024)
B Pernas, Gloria Iacoboni, I Los-Arcos, C Carpio, E Márquez-Algaba, M A Sanchez-Salinas, A Albasanz, J Esperalba, B Viñado, I Ruiz Camps, Pere Barba
Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis. European journal of haematology 113 (2) (2024)
Gloria Iacoboni, Mario A Sánchez-Salinas, Kai Rejeski, Ana Á Martín-López, Mi Kwon, Víctor Navarro, Katarzyna Aleksandra Jalowiec, Rafael Hernani, Juan L Reguera-Ortega, Laura Gallur, Viktoria Blumenberg, María Herrero-García, Claire Roddie, Ana Benzaquén, Javier Delgado-Serrano, Rebeca Bailén, Cecilia Carpio, Paula Amat, Lucia López-Corral, Lourdes Martín-Martín, Mariana Bastos, Marion Subklewe, Maeve O'Reilly, Pere Barba
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells. HemaSphere 8 (7) (2024)
Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Emmanuel Bachy, Josu Iraola-Truchuelo, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Bastien Lesne, Mi Kwon, Romain Gounot, Nuria Martínez-Cibrian, Cristina Castilla-Llorente, Pau Abrisqueta, Manuel Guerreiro, Clémentine Sarkozy, José María Aspa-Cilleruelo, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Erick Deconinck, Krimo Bouabdallah, Francesc Bosch, Pere Barba, Judith Trotman, Houot Roch
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma. Blood 144 (3) (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in CAR T-cell patients? Blood advances (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy? Blood advances 8 (9) (2024)
Gilles Crochet, Gloria Iacoboni, Audrey Couturier, Emmanuel Bachy, Josu Iraola-Truchuelo, Thomas Gastinne, Guillaume Cartron, Tom Fradon, Bastien Lesne, Mi Kwon, Romain Gounot, Nuria Martínez-Cibrian, Cristina Castilla-Llorente, Pau Abrisqueta, Manuel Guerreiro, Clémentine Sarkozy, José María Aspa-Cilleruelo, Vincent Camus, Stéphanie Guidez, Adrien Chauchet, Erick Deconinck, Krimo Bouabdallah, Francesc Bosch, Pere Barba, Judith Trotman, Houot Roch
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma. Blood (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in CAR T-cell patients? Blood advances (2024)
Gloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, Víctor Navarro, Tobias Menne, Mi Kwon, Ana África Martín-López, Sridhar Chaganti, Javier Delgado, Claire Roddie, Ariadna Pérez, Jane Norman, Manuel Guerreiro, Adam Gibb, Ana Carolina Caballero, Caroline Besley, Nuria Martínez-Cibrián, Alberto Mussetti, Robin Sanderson, Hugo Luzardo, Sunil Iyengar, Jose Maria Sánchez, Ceri Jones, Juan-Manuel Sancho, Pere Barba, Anne-Louise Latif, Lucia López-Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Alejandro Martin Garcia-Sancho, Mariana Bastos, Pau Abrisqueta, Andrea Kuhnl
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy. HemaSphere 8 (5) (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Gloria Iacoboni, Josu Iraola-Truchuelo, Maeve O'Reilly, Víctor Navarro, Tobias Menne, Mi Kwon, Ana África Martín-López, Sridhar Chaganti, Javier Delgado, Claire Roddie, Ariadna Pérez, Jane Norman, Manuel Guerreiro, Adam Gibb, Ana Carolina Caballero, Caroline Besley, Nuria Martínez-Cibrián, Alberto Mussetti, Robin Sanderson, Hugo Luzardo, Sunil Iyengar, Jose Maria Sánchez, Ceri Jones, Juan-Manuel Sancho, Pere Barba, Anne-Louise Latif, Lucia López-Corral, Rafael Hernani, Juan Luis Reguera, Anna Sureda, Alejandro Martin Garcia-Sancho, Mariana Bastos, Pau Abrisqueta, Andrea Kuhnl
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy. HemaSphere 8 (5) (2024)
Gloria Iacoboni, Mario A Sánchez-Salinas, Kai Rejeski, Ana Á Martín-López, Mi Kwon, Víctor Navarro, Katarzyna Aleksandra Jalowiec, Rafael Hernani, Juan L Reguera-Ortega, Laura Gallur, Viktoria Blumenberg, María Herrero-García, Claire Roddie, Ana Benzaquén, Javier Delgado-Serrano, Rebeca Bailén, Cecilia Carpio, Paula Amat, Lucia López-Corral, Lourdes Martín-Martín, Mariana Bastos, Marion Subklewe, Maeve O'Reilly, Pere Barba
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells. HemaSphere 8 (7) (2024)
B Pernas, Gloria Iacoboni, I Los-Arcos, C Carpio, E Márquez-Algaba, M A Sanchez-Salinas, A Albasanz, J Esperalba, B Viñado, I Ruiz Camps, Pere Barba
Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis. European journal of haematology (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Marion Subklewe, Yucai Wang, Doris K Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Andreas Bethge, Javier Munoz, Razan Mohty, Veit L Bücklein, Pere Barba, Frederick L Locke, Yi Lin, Michael D Jain, Marion Subklewe
Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood advances 8 (8) (2024)
Gloria Iacoboni, Mario A Sánchez-Salinas, Kai Rejeski, Ana Á Martín-López, Mi Kwon, Víctor Navarro, Katarzyna Aleksandra Jalowiec, Rafael Hernani, Juan L Reguera-Ortega, Laura Gallur, Viktoria Blumenberg, María Herrero-García, Claire Roddie, Ana Benzaquén, Javier Delgado-Serrano, Rebeca Bailén, Cecilia Carpio, Paula Amat, Lucia López-Corral, Lourdes Martín-Martín, Mariana Bastos, Marion Subklewe, Maeve O'Reilly, Pere Barba
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells. HemaSphere 8 (7) (2024)
Mario Andrés Sánchez-Salinas, Marta Miarons, Iñaki F Trocóniz, Víctor Navarro, Javier Varela, Gloria Iacoboni, Pere Barba
Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy? Blood advances 8 (9) (2024)
Kai Rejeski, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Cristina Balduzzi, Pere Barba, Benedetto Bruno, Reuben Benjamin, Matteo Giovanni Giovanni Carrabba, Christian Chabanon, Fabio Ciceri, Paolo Corradini, Julio Delgado, Roberta Di Blasi, Raffaella Greco, Houot Roch, Gloria Iacoboni, Ulrich Jäger, Marie José Kersten, Stephan Mielke, Arnon Nagler, Francesco Onida, Zinaida Peric, Claire Roddie, Annalisa Ruggeri, Fermin M Sanchez-Guijo, Isabel Sánchez-Ortega, Dominik Schneidawind, Maria-Luisa Schubert, John A Snowden, Catherine Thieblemont, Max S Topp, Pier Luigi Luigi Zinzani, John G Gribben, Chiara Bonini, Anna Sureda Balari, Ibrahim Yakoub Agha
Immune Effector Cell-Associated Hematotoxicity (ICAHT): EHA/EBMT Consensus Grading and Best Practice Recommendations. Blood (2023)
Gloria Iacoboni, Víctor Navarro, Ana África Martín-López, Marion Subklewe, Mi Kwon, Katarzyna Aleksandra Jalowiec, Paula Amat, Juan Luis Reguera-Ortega, Laura Gallur, Viktoria Blumenberg, Sara Gutiérrez-Herrero, Claire Roddie, Ana Benzaquén, Javier Delgado-Serrano, Mario Andrés Sánchez-Salinas, Rebeca Bailén, Cecilia Carpio, Lucia López-Corral, Rafael Hernani, Mariana Bastos-Oreiro, Maeve A O'Reilly, Lourdes Martín-Martín, Marion Subklewe, Pere Barba
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Marion Subklewe, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla M Reid, Rawan G Faramand, Marco L Davila, Karnav Modi, Erin A Dean, Christina A Bachmeier, Michael von Bergwelt-Baildon, Frederick L Locke, Wolfgang Andreas Bethge, Lars Bullinger, Andreas Mackensen, Pere Barba, Michael D Jain, Marion Subklewe
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Science advances 9 (38) (2023)
Irene Medina, Cecilia Carpio, Isabel Ruiz-Camps, Adaia Albasanz-Puig, Oriana Lopez-Godino, Juliana Esperalba, Francisco Beas, Mario Sanchez-Salinas, Gloria Iacoboni, Pere Barba
Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma. Immunotherapy (2023)
Viktoria Blumenberg, Busch Galina, Stephan Baumann, Regina Jitschin, Gloria Iacoboni, Eva Hoster, Laura Gallur, Josu Iraola-Truchuelo, Michael Winkelmann, Konstantin Hellwig, Christian Schmidt, Lisa Frölich, Benjamin Tast, Friederike Hildebrand, Kai Rejeski, Franziska J Dekorsy, Christian Schmidkonz, Tobias Bäuerle, Wolfgang Gerhard Kunz, Dimitrios Mougiakakos, Fabian Müller, Michael von Bergwelt-Baildon, Pere Barba, Veit L Bücklein, Andreas Mackensen, Simon Völkl, Marion Subklewe
Early quantification of anti-CD19 CAR T-cells by flow cytometry predicts response in R/R DLBCL. Blood advances (2023)
Pau Abrisqueta, Daniel Medina, Guillermo Villacampa, JunYan Lu, Miguel Alcoceba, Julia Carabia, Joan Boix, Barbara Tazón-Vega, Gloria Iacoboni, Sabela Bobillo, Ana Marin-Niebla, Marcos González-Díaz, Thorsten Zenz, Marta Crespo, Francesc Bosch
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression. Blood advances 6 (21) (2022)
Marion Subklewe, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit L Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas A Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood advances 6 (16) (2022)
Eva Catalá, Gloria Iacoboni, Ángela Vidal-Jordana, Gerard Oristrell, Cecilia Carpio, Andreu Vilaseca, Alba Cabirta, Francesc Bosch, Mar Tintoré, Pere Barba
Neurotoxicity-associated sinus bradycardia after chimeric antigen receptor T-cell therapy. Hematological oncology 40 (3) (2022)
Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucía López Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Martin Garcia-Sancho, Pier Luigi Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma. Blood advances 6 (12) (2022)
Martin Hutchings, Franck Morschhauser, Gloria Iacoboni, Carmello Carlo-Stella, Fritz C Offner, Anna Sureda, Gilles Andre Salles, Joaquín Martínez-Lopez, Michael Crump, Denise N Thomas, Peter N Morcos, Cristiano Ferlini, Ann-Marie E Bröske, Anton Belousov, Marina Bacac, Natalie Dimier, David J Carlile, Linda Lundberg, David Perez-Callejo, Pablo Umaña, Tom Moore, Martin Weisser, Michael J Dickinson
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (18) (2021)
Gloria Iacoboni, Guillermo Villacampa, Nuria Martinez-Cibrian, Rebeca Bailén, Lucia Lopez Corral, Jose M Sanchez, Manuel Guerreiro, Ana Carolina Caballero, Alberto Mussetti, Juan-Manuel Sancho, Rafael Hernani, Pau Abrisqueta, Carlos Solano, Anna Sureda, Javier Briones, Alejandro Martin Garcia-Sancho, Mi Kwon, Juan Luis Reguera-Ortega, Pere Barba, null null
Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma. Cancer medicine 10 (10) (2021)
Gloria Iacoboni, Marc Simó, Guillermo Villacampa, Eva Catalá, Cecilia Carpio, Cándido Díaz-Lagares, Ángela Vidal-Jordana, Sabela Bobillo, Ana Marín-Niebla, Ana Pérez, Moraima Jiménez, Pau Abrisqueta, Francesc Bosch, Pere Barba
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy. Annals of hematology 100 (9) (2021)